Stock 6919 CALIWAY BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Caliway Biopharmaceuticals Co., Ltd.

Equities

6919

TW0006919004

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
681 TWD +0.74% Intraday chart for Caliway Biopharmaceuticals Co., Ltd. -3.95% +256.08%
May. 13 Caliway Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Caliway Biopharmaceuticals Co., Ltd. Announces CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CALIWAY BIOPHARMACEUTICALS CO., LTD. Stock Caliway Biopharmaceuticals Co., Ltd.
 2.92B - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
 324B
ABBVIE INC. Stock AbbVie Inc.
 301B
  1. Stock Market
  2. Equities
  3. 6919 Stock
  4. Charts Caliway Biopharmaceuticals Co., Ltd.
  5. Sector Chart